Sunday, 24 Aug 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    TACC Limited and CRRI Collaborate to Revolutionize Indian Infrastructure with Graphene-Enhanced Pavements
    TACC Limited and CRRI Collaborate to Revolutionize Indian Infrastructure with Graphene-Enhanced Pavements
    24/08/2025
    DXC Named a Leader in Everest Group’s Custom Application Development Services PEAK Matrix Assessment 2025 Report
    DXC Named a Leader in Everest Group’s Custom Application Development Services PEAK Matrix Assessment 2025 Report
    24/08/2025
    Remembering the Life and Legacy of Lord Swraj Paul
    Remembering the Life and Legacy of Lord Swraj Paul
    23/08/2025
    Starburst Announces AI & Datanova 2025, an Exclusive In-Person Summit for Data and AI Leaders
    Starburst Announces AI & Datanova 2025, an Exclusive In-Person Summit for Data and AI Leaders
    23/08/2025
    Jiohotstar Reveals the Bigg Boss 19 House, the Stage for This ‘Gharwalo Ki Sarkaar’
    Jiohotstar Reveals the Bigg Boss 19 House, the Stage for This ‘Gharwalo Ki Sarkaar’
    23/08/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • june
  • global
  • july
  • Business
  • today
  • announced
  • company
  • Tech
  •  and
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Health

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNews Wire
Last updated: 02/08/2025 7:21 PM
GlobeNews Wire
Share
3 Min Read
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SHARE
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025 17:06 ET  | Source: Taysha Gene Therapies, Inc.

DALLAS, Aug. 01, 2025 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on August 1, 2025, the Compensation Committee of Taysha’s Board of Directors granted one new employee an option to purchase 90,000 shares of the Company’s common stock in connection with their employment. The stock option was granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individual entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).

The stock option has an exercise price of $2.63 which is equal to the closing price of Taysha’s common stock on the date of grant. The stock option has a 10-year term and will vest over four years, with 25% of the option vesting on the first anniversary of the vesting commencement date and the remaining 75% of the option vesting in equal monthly installments over the 36 months thereafter. Vesting of the stock option is subject to such employee’s continued service to Taysha on each vesting date.

About Taysha Gene Therapies
Taysha Gene Therapies (Nasdaq: TSHA) is a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system. Its lead clinical program TSHA-102 is in development for Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. With a singular focus on developing transformative medicines, Taysha aims to address severe unmet medical needs and dramatically improve the lives of patients and their caregivers. The Company’s management team has proven experience in gene therapy development and commercialization. Taysha leverages this experience, its manufacturing process and a clinically and commercially proven AAV9 capsid in an effort to rapidly translate treatments from bench to bedside. For more information, please visit http://www.tayshagtx.com.

Company Contact:
Hayleigh Collins
Senior Director, Corporate Communications and Investor Relations
Taysha Gene Therapies, Inc.
hcollins@tayshagtx.com

Media Contact:
Carolyn Hawley
Inizio Evoke
Carolyn.hawley@inizioevoke.com

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL
Brandwatch and Trajaan Partner to Bring World-Class Search Intelligence to Consumer Insights
ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm
Sonata Software Q1 FY26 Consolidated PAT Grew 1.7% QoQ, And Announces First Interim Dividend of Rupees 1.25 Per Share
Groq and HUMAIN Launch OpenAI’s New Open Models Day Zero
TAGGED:5635(c)(4)adenoassociatedadvancingAdventureannouncesaugaugustbiotechnologyclinicalstagecommoncompanydallasdateemploymentequalfocusedgeneglobegrantgrantedincinducementlistingnasdaqNasdaq:TSHAnewsnewswireoptionpricerulesourcestocktayshatayshastherapiestshaunderUS8776191061vesting
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

Remembering the Life and Legacy of Lord Swraj Paul
Food

MEDAS contracts order for the largest multi-feed, ethanol plant in Maharashtra at 500,000 lpd from NSL (Jay Mahesh Unit, Mazalgaon)

11/08/2025

Euro NCAP highlights safety flaws in new models as five cars secure top ratings

10/07/2025
Remembering the Life and Legacy of Lord Swraj Paul
Business

FIS Unveils InnovateIN48 Champions as Technologists Push the Boundaries of AI

13/07/2025
Flipster Unveils the First Zero-Spread Model in Crypto Perpetuals Trading
Business

Flipster Unveils the First Zero-Spread Model in Crypto Perpetuals Trading

18/08/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?